Aehr Test Systems (NASDAQ:AEHR) Reaches New 1-Year High - Time to Buy?

Aehr Test Systems (NASDAQ:AEHR - Get Free Report)'s stock price hit a new 52-week high during trading on Tuesday . The company traded as high as $21.82 and last traded at $19.39, with a volume of 3254273 shares traded. The stock had previously closed at $16.45.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of Aehr Test Systems to a "sell" rating in a research note on Tuesday, May 13th.

Aehr Test Systems Stock Up 23.6%

The company's fifty day moving average is $11.75 and its 200 day moving average is $10.67. The stock has a market cap of $605.37 million, a PE ratio of -159.94 and a beta of 2.29.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last released its earnings results on Tuesday, July 8th. The semiconductor company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.02) by $0.01. Aehr Test Systems had a negative return on equity of 0.15% and a negative net margin of 6.63%. The business had revenue of $14,100 billion during the quarter, compared to analysts' expectations of $14.83 million. Equities analysts expect that Aehr Test Systems will post 0.1 EPS for the current year.

Insiders Place Their Bets

In related news, VP Alistair N. Sporck sold 3,000 shares of the business's stock in a transaction that occurred on Tuesday, July 15th. The stock was sold at an average price of $14.13, for a total value of $42,390.00. Following the completion of the sale, the vice president owned 30,808 shares in the company, valued at $435,317.04. The trade was a 8.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Alberto Salamone sold 4,995 shares of the firm's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $9.08, for a total value of $45,354.60. Following the completion of the transaction, the executive vice president directly owned 56,241 shares in the company, valued at $510,668.28. The trade was a 8.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 6.20% of the company's stock.

Hedge Funds Weigh In On Aehr Test Systems

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Quantbot Technologies LP bought a new position in Aehr Test Systems in the 1st quarter valued at about $31,000. GAMMA Investing LLC grew its holdings in Aehr Test Systems by 1,753.1% during the 1st quarter. GAMMA Investing LLC now owns 7,079 shares of the semiconductor company's stock valued at $52,000 after buying an additional 6,697 shares in the last quarter. State of Wyoming bought a new stake in shares of Aehr Test Systems during the fourth quarter worth $67,000. American Century Companies Inc. acquired a new stake in Aehr Test Systems in the 1st quarter worth approximately $86,000. Finally, Headlands Technologies LLC acquired a new position in shares of Aehr Test Systems during the 4th quarter worth approximately $103,000. Institutional investors and hedge funds own 69.69% of the company's stock.

Aehr Test Systems Company Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.